Marvelon
Sponsors
Bayer, University of Saskatchewan, Organon and Co, Tehran University of Medical Sciences, University of Toronto
Conditions
ContraceptionIn-vitro FertilizationInfertilityLightMenstrual ProblemOvarian FolliclePrimary DysmenorrheaTraditional Chinese Medicine
Phase 2
Phase 3
Phase 4
Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)
CompletedNCT00778999
Start: 2006-10-01End: 2008-07-24Updated: 2022-02-04
New Treatments for Troublesome Bleeding in Implanon Users
NCT01384331
Start: 2011-07-31End: 2013-04-30Target: 200Updated: 2011-06-29
Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy(LLLT) for Primary Dysmenorrhea(PD)
NCT03953716
Start: 2019-06-22End: 2020-06-30Target: 480Updated: 2019-06-25
Unknown Phase
Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women
CompletedNCT00565240
Start: 2007-11-30End: 2009-09-30Updated: 2010-04-22
NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment
TerminatedNCT01298128
Start: 2006-02-28End: 2010-12-31Updated: 2012-10-05